Omnicell anticipates 2025 total revenue to range from $1.105 million to $1.155 million, with product bookings expected between $500 million and $550 million and annual recurring revenue ( ARR) ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with ...

Healthcare tech company Omnicell (NASDAQ:OMCL ... However, headwinds such as tightening hospital budgets, cybersecurity threats, and the fragmented nature of healthcare systems could slow adoption.

The Pittsburgh region has seen more than its share of commercialized safety innovations that have been born and bred in our ...

Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6. The target ...

Ares Management Corporation ("Ares") announced today that an Ares Credit fund served as the administrative and collateral agent on a financing package to support the recapitalization of Global ...

Image Source: Zacks Investment Research The benefits of laparoscopic or minimally invasive surgery to patients and surgeons, including improved screening, increased precision, shorter hospital ...